CRC Clinical Trial - The Efficacy of HLX208 (BRAF V600E Inhibitor) With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05002270` - JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation	Phase 1/Phase 2
Recruiting	`NCT04557449` - Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT04981119` - Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Active, not recruiting	`NCT01308086` - Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer	Phase 3
Active, not recruiting	`NCT04585035` - Study to Evaluate D-1553 in Subjects With Solid Tumors	Phase 1/Phase 2
Completed	`NCT03665285` - A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT03336658` - Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
Terminated	`NCT03875313` - Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT05382377` - NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors	Early Phase 1
Active, not recruiting	`NCT05314309` - Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
Recruiting	`NCT06259552` - A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors	Phase 1
Completed	`NCT05976282` - Addressing Colorectal Cancer in South Florida Firefighters	N/A
Recruiting	`NCT01593098` - A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)
Recruiting	`NCT03597581` - A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in 2nd Line RAS Mutant Advanced Colorectal Cancer	Phase 1
Terminated	`NCT05368688` - Microbiome in Colorectal Cancer Onset and Progression
Completed	`NCT03965845` - A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors	Phase 1/Phase 2
Not yet recruiting	`NCT03601598` - A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC	Phase 1/Phase 2
Recruiting	`NCT05009329` - FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China	Phase 1/Phase 2
Completed	`NCT02161549` - Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy	N/A
Active, not recruiting	`NCT04868773` - Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy	Phase 1

NCT number	NCT04984369
Study type	Interventional
Source	Shanghai Henlius Biotech
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	August 11, 2021
Completion date	January 15, 2025

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms